PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 155 filers reported holding PRECIGEN INC in Q4 2020. The put-call ratio across all filers is 1.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,594 | +85.1% | 79,994 | +83.3% | 0.04% | +70.8% |
| Q1 2023 | $46,251 | +71055.4% | 43,633 | +1.6% | 0.02% | -44.2% |
| Q4 2022 | $65 | -99.9% | 42,933 | -2.1% | 0.04% | -45.6% |
| Q3 2022 | $93,000 | +55.0% | 43,833 | -3.6% | 0.08% | +43.6% |
| Q2 2022 | $60,000 | -13.0% | 45,458 | +38.1% | 0.06% | +103.7% |
| Q1 2022 | $69,000 | -42.5% | 32,918 | +2.2% | 0.03% | -22.9% |
| Q4 2021 | $120,000 | -30.2% | 32,218 | -6.7% | 0.04% | -41.7% |
| Q3 2021 | $172,000 | -35.6% | 34,532 | -15.6% | 0.06% | -49.2% |
| Q2 2021 | $267,000 | -36.4% | 40,932 | -0.5% | 0.12% | -56.5% |
| Q4 2020 | $420,000 | +79.5% | 41,132 | +22.4% | 0.27% | +194.6% |
| Q3 2020 | $234,000 | +24.5% | 33,609 | -11.0% | 0.09% | -61.8% |
| Q2 2020 | $188,000 | +63.5% | 37,752 | +11.9% | 0.24% | +8.1% |
| Q1 2020 | $115,000 | – | 33,738 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |